Insulin-like growth factor (IGF)-signalling pathway components are potential therapeutic targets in the treatment of human hepatocellular carcinoma;Insulin-like growth factor (IGF)-Signalwegskomponenten sind potentielle therapeutische Zielstrukturen bei der Behandlung des hepatozellulären Karzinoms.

Verhandlungen der Deutschen Gesellschaft für Pathologie

Volumn 91, Issue , 2007, Pages 278-285

  Nussbaum, T ^a   Samarin, J ^a   Schirmacher, P ^a   Breuhahn, K ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; SOMATOMEDIN B;

ARTICLE; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 42949104106     PISSN: 00704113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)